Suppr超能文献

通过有限稀释分析证明人肾移植受者中供体特异性分泌白细胞介素-2细胞和细胞毒性T淋巴细胞前体的持续存在。

Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis.

作者信息

Lantz O, Alard P, Ben Aribia M H, Chavanel G, Fries D, Senik A, Charpentier B

机构信息

Laboratoire d'Immunologie Cellulaire et de Transplantation, ER 277 CNRS, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.

出版信息

J Immunol. 1990 May 15;144(10):3748-55.

PMID:2332630
Abstract

The low reactivity to donor alloantigens reported in PBL from kidney transplant recipients might be related to clonal deletion and/or suppression of donor-specific alloreactive cells. To discriminate between these two hypotheses, we quantified the number of IL-2 secreting cells (IL-2-SC) and of cytotoxic precursors (CTLp) in the T cells from tolerant recipients when stimulated with either donor specific or nonrelated third-party LCL. To eliminate the irrelevant reactivity, we used as responding cells high-density T cells that had been depleted of such reactivity by 4 days preculture with autologous lymphoblastoid cell line in the presence of bromodeoxyuridine. Thus, frequencies of IL-2-SC and CTLp specifically directed at alloantigens could be measured. In 11 recipients, there was no strong decrease in the frequency of donor-reactive T cells when compared to the frequency of those directed at a third-party lymphoblastoid cell line, either for IL-2-SC (tested in 11 patients) or for CTLp (tested in 6 patients). In three cases of seven, a suppression was observed only when T cells were stimulated by donor cells. These data suggest that donor-reactive cells are still present in PBL of kidney-transplant recipients tested from 6 mo to 4 y posttransplantation. Moreover, suppression of donor-specific cells can be demonstrated in peripheral T cells of some recipients, which may account in part for the absence of rejection.

摘要

肾移植受者外周血淋巴细胞(PBL)中报道的对供体同种异体抗原的低反应性可能与供体特异性同种异体反应性细胞的克隆清除和/或抑制有关。为了区分这两种假设,我们在用供体特异性或无关第三方淋巴母细胞系(LCL)刺激时,对耐受受者T细胞中分泌白细胞介素-2的细胞(IL-2-SC)和细胞毒性前体(CTLp)的数量进行了定量。为了消除无关反应性,我们使用高密度T细胞作为反应细胞,这些T细胞在溴脱氧尿苷存在下与自体淋巴母细胞系预培养4天,已消除了这种反应性。因此,可以测量特异性针对同种异体抗原的IL-2-SC和CTLp的频率。在11名受者中,与针对第三方淋巴母细胞系的T细胞频率相比,供体反应性T细胞的频率没有明显下降,无论是对于IL-2-SC(在11名患者中测试)还是对于CTLp(在6名患者中测试)。在7例中的3例中,仅当T细胞受到供体细胞刺激时才观察到抑制作用。这些数据表明,在移植后6个月至4年测试的肾移植受者的PBL中,供体反应性细胞仍然存在。此外,在一些受者的外周T细胞中可以证明对供体特异性细胞的抑制作用,这可能部分解释了无排斥反应的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验